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Summary
Neuromuscular decline occurs with aging. The neuromuscular junction (NMJ), the
interface between motor nerve and muscle, also undergoes age-related changes.
Aging effects on the NMJ components—motor nerve terminal, acetylcholine recep-
tors (AChRs), and nonmyelinating terminal Schwann cells (tSCs)—have not been
comprehensively evaluated. Sirtuins delay mammalian aging and increase longevity.
Increased hypothalamic Sirt1 expression results in more youthful physiology, but the
relationship between NMJ morphology and hypothalamic Sirt1 was previously
unknown. In wild-type mice, all NMJ components showed age-associated morpho-
logical changes with ~80% of NMJs displaying abnormalities by 17 months of age.
Aged mice with brain-specific Sirt1 overexpression (BRASTO) had more youthful
NMJ morphologic features compared to controls with increased tSC numbers,
increased NMJ innervation, and increased numbers of normal AChRs. Sympathetic
NMJ innervation was increased in BRASTO mice. In contrast, hypothalamic-specific
Sirt1 knockdown led to tSC abnormalities, decreased tSC numbers, and more dener-
vated endplates compared to controls. Our data suggest that hypothalamic Sirt1
functions to protect NMJs in skeletal muscle from age-related changes via sympa-
thetic innervation.
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1 | INTRODUCTION
Muscle function is essential to overall health, stability, and safe
mobility. Aging is associated with progressive skeletal muscle mass
decline, muscle fiber denervation, and motor unit loss and remodel-
ing (Santulli & Iaccarino, 2013). With age, degenerative changes
may affect not only muscle and nerve, but also the interface
between the two, the neuromuscular junction (NMJ). The NMJ is
integral to motor function; it is a cholinergic synapse that controls
muscle contraction. The NMJ does not have a fixed, permanent
structure, but instead shows plasticity in response to muscle injury,
disease, and aging. It is composed of three main elements: the
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2018 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.




wileyonlinelibrary.com/journal/acel | 1 of 15
motor nerve terminal, acetylcholine receptors (AChRs), and special-
ized glial cells termed perisynaptic Schwann cells or terminal Sch-
wann cells (tSCs). Unlike the myelinating Schwann cells that
surround motor nerve axons, tSCs are nonmyelinating glial cells that
surround nerve terminals at the NMJ. tSCs regulate morphological
stability and function of the NMJ and play a critical role in regulat-
ing the nerve–muscle interface with important roles in synaptic
regeneration in homeostasis (Reddy, Koirala, Sugiura, Herrera & Ko,
2003), after injury (Kang, Tian & Thompson, 2003), and in aging
(Griffin & Thompson, 2008).
Age-associated NMJ degeneration is well characterized in ani-
mals and humans (Balice-Gordon, 1997; Boaro, Soares & Konig,
1998; Deschenes, Roby, Eason & Harris, 2010; Jang & Van Remmen,
2010; Kawabuchi et al., 2001; Luff, 1998; McMullen & Andrade,
2009; Smith & Chapman, 1987; Steinbach, 1981; Wernig & Herrera,
1986). Aging results in progressive NMJ degradation causing a
steady decline in muscle mass and strength, termed senile muscle
atrophy, or sarcopenia. Interactions among tSCs, presynaptic nerve
terminals, and postsynaptic endplates and muscle play critical roles
in synaptic growth, maintenance, and survival. The exchange of
trophic factors has been implicated in pre- and postsynaptic devel-
opment as well as preserving neuronal and synaptic plasticity at the
NMJ. In addition, factors such as mitochondrial dysfunction, oxida-
tive stress, inflammation, changes in muscle fiber innervation, and
motor unit mechanical properties probably contribute to NMJ
degeneration. Interventions such as caloric restriction and exercise
may positively affect the NMJ and attenuate the age-related pro-
gressive impairment in motor function (Valdez et al., 2010).
A mammalian sirtuin, Sirt1, controls several age-associated
pathophysiological processes in energy homeostasis, cognitive func-
tion, emotion, and neurogenesis (Satoh, Imai & Guarente, 2017).
Recent studies have demonstrated that hypothalamic Sirt1 regulates
mammalian aging and longevity in mice. Stereotactic injection of
Sirt1-expressing lentiviruses into the dorsomedial hypothalamus
(DMH) of aged adult wild-type (WT) mice ameliorates age-associated
declines in physical activity and body temperature, supporting the
notion that the hypothalamus, specifically the DMH, is one of the
control centers for mammalian aging and longevity (Satoh et al.,
2010, 2013). Mice with brain-specific overexpression of Sirt1
(BRASTO) show a significant delay in aging with extended lifespans
in both males and females (Satoh et al., 2013). Specifically, skeletal
muscle in BRASTO mice maintains youthful morphology and mito-
chondrial function during the aging process due to enhanced sympa-
thetic nervous tone during the dark period. Although the mechanism
by which the signal from the hypothalamus is specifically directed to
skeletal muscle remains unknown, increased sympathetic tone may
contribute to skeletal muscle and NMJ changes and increased long-
evity to delay the effects of aging.
Sympathetic innervation controls muscle metabolism, mainte-
nance, and function of nerve–muscle contact (Roatta & Farina,
2009). There are a few studies reporting on direct innervation of
skeletal muscle fibers by nonmyelinated, noradrenergic fibers (Barker
& Saito, 1981; Lynch & Ryall, 2008), suggesting that sympathetic
actions on skeletal muscle are at least partially mediated by neural
mechanisms. It has been reported that sympathetic neurons coinner-
vate several targets in muscle, including blood vessels, motor neu-
rons, muscle fibers, and NMJs (Khan et al., 2016; Rudolf et al.,
2013). Moreover, cAMP/PKA-dependent signaling at the NMJ is
important for synapse stabilization and metabolic control of AChR
function (Li, Yi & Thompson, 2011).
This study examines the effects of aging on all components of
the NMJ, including tSCs. In addition, we investigate the impact of
differing levels of brain or hypothalamic Sirt1 expression on NMJ
architecture in skeletal muscle and suggest a role for sympathetic
innervation in mediating the systemic effects of central Sirt1 changes
at the level of the NMJ.
2 | RESULTS
2.1 | Body mass and sternomastoid (SM) mass
decrease with age in WT mice
Peak average body weight occurred at 14 months of age
(41.34  4.9 g) and declined by 26% by 33 months of age
(30.67  3.0 g) in WT mice. Wet weight of the SM muscle in isola-
tion paralleled total body mass with a 33% decline in mass between
14 and 33 months of age (0.021  0.003 g and 0.014  0.001 g,
respectively; Table 1).
2.2 | NMJ morphologic abnormalities increase with
age in WT mice
Confocal and fluorescent images of tSCs (labeled with S100 Ab),
presynaptic nerve terminals (labeled with NF200 and SV2 Abs), and
postsynaptic endplates (stained with a-BTX, which is specific for
AChRs) enabled visualization and analyses of NMJs in SM muscles
of 3-, 9-, 14-, 17-, 25-, 29-, and 33-month-old WT mice. NMJs from
mice between 3 and 9 months of age showed normal morphological
characteristics including 2–5 tSCs, a single nerve terminal, and
branched, pretzel-like AChR staining at each NMJ (Figure 1a–c). In
contrast, NMJ organization was altered in all groups of aged mice
from 14 through 33 months of age, with >90% of NMJs demonstrat-
ing some type of morphologic abnormality by age 29 months. Aged
mice showed coincidental abnormalities of the tSCs, nerve terminals,
TABLE 1 Body weight and SM muscle mass
Age (months) Mice genotype Body mass (g) SM muscle mass (g)
3 WT 26.68  1.0 0.012  0.001
9 WT 28.04  3.0 * 0.013  0.001 *
14 WT 41.34  4.9 0.021  0.003
17 WT 37.77  4.8 0.019  0.006
29 WT 34.25  3.2 * 0.017  0.001 *
33 WT 30.67  3.0 0.014  0.001
Data represent mean  SD (N = 3–9 mice/group).
*p < .05.
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and endplates (Figures 1d–f and 2), which are described in detail
below.
2.2.1 | Terminal Schwann cells
The Schwann cell marker S100 was present in tSCs at the NMJ,
and these cells had ovoid-shaped nuclei and cytoplasmic processes
that colocalized with AChRs. tSCs in young adult mice were present
in almost 100% of NMJs and stayed in contact with the entire end-
plate (Figures 1 and 2a). In contrast, tSC numbers decreased with
age (Figure 1f). The percentage of NMJs with tSCs present
decreased significantly (p < .05) from 100% at 9 months of age to
11.2  1.9% at 33 months of age (Figure 2a). In addition, tSC bod-
ies exhibited irregular contour and variability in staining intensity
with S100 Ab (Figure 2a). tSC processes were thinner with advanc-
ing age, but overall were less affected by mouse age than tSC bod-
ies (data not shown).
2.2.2 | Presynaptic nerve terminal
NMJ innervation was evaluated with immunostaining with NF200
Ab and a-BTX to identify the presence of nerve terminals. For quan-
tification, NMJs were divided into three groups: (i) fully innervated,
(ii) partially innervated (less branching or fragmented), and (iii) not
 S100 BTX DAPI  NF200 BTX DAPI
 S100 BTX DAPI
(a) (b)  3 m
(c) (d)
(e) (f)
   9 m
 3 m
14 m
17 m 29 m
F IGURE 1 Representative confocal
images of NMJ morphology in the
sternomastoid muscle of adult WT mice
with age. (a–c) Characteristic NMJ
morphology is seen in 3- and 9-month-old
mice with clusters of tSCs (arrows, a, c)
near the nerve terminal (arrows, b) and
AChR staining (arrowheads, b). (d–f)
Representative images of NMJs
demonstrate less colocalization of tSCs
(arrows) and AChRs (arrowheads) with
advancing age. AChRs acquire a
fragmented and granular appearance with
age (arrowheads in e, f). S100 Ab (for SCs);
NF200 Ab = antineurofilament antibody;
BTX = a-bungarotoxin (for AChRs);
DAPI = nuclear staining; m = months;
Scale bar = 20 lm
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innervated (denervated) (Figure 2b). Nerve terminals from young
adults were distinct, branching, and colocalized with endplates (a-
BTX staining) (Figure 1b). NMJ innervation significantly (p < .05)
decreased with age beginning at 14 months of age with denervation
of nearly 20% of NMJs (Figure 2b). The percentage of fully dener-
vated NMJs increased to over 35% at 17 months of age, but then
decreased again until advanced age (33 months) (Figure 2b). Aged
mice demonstrated almost no nerve branching and frequently had
no nerve terminal associated with the NMJ. Some nerve sprouting
was observed only in 14-month-old mice, but by 33 months of age,
nearly half of the assessed NMJs were denervated (Figure 2b). Vari-
ability in nerve morphology was also seen, including enlarged and
spherical nerve ends as well as thin axon terminals (Figure 2b).
2.2.3 | Motor endplates (AChRs)
Age-associated changes on postsynaptic AChRs were characterized
after immunostaining with a-BTX, and the number of AChR fragments
per NMJ was evaluated (Figures 1 and 2c). Data are presented as per-
centage of NMJs that contain normal, partially fragmented, or fully
fragmented AChRs. Most endplates from young mice (Figures 1 and
2c) formed normal, pretzel-shaped, synaptic gutters consisting of a
continuous structure with less than five fragments. Endplates from
aged mice formed a single cluster (often diffusive) or were more frag-
mented or granular (Figures 1 and 2c). At 14 months of age, ~34% of
NMJs showed partial or full fragmentation which increased drastically
between 17 and 33 months of age (p < .05). By 33 months of age,
only ~12% of AChRs showed normal morphology.
2.3 | Aged BRASTO mice have a more youthful
NMJ morphology than WT mice
Each of the three main NMJ components (tSCs, nerve terminal, and
AChRs) was compared in young (7-month-old) and aged (25- and 33-
month-old) BRASTO mice and age-matched WT controls qualitatively
(Figure 3) and quantitatively (Figure 4). NMJ morphology in young (7-
month-old)BRASTOmicedidnotdiffer fromcharacteristic, healthyNMJ
morphology seen in age-matched controls (Figure 3a–d). When mice
became old, more tSC processes and tSC bodies were observed at the
NMJ in SM muscles of BRASTO mice compared to controls (Figures 3
and 4a). The percentage of NMJs with tSC bodies present significantly
(p < .05) increased and was nearly double that of controls at 33 months
of age (Figure 4a). Similarly, thepercentageof fully innervatedNMJswas
significantly higher in the aged BRASTO SM muscles compared to
controls at both ages (p < .05, Figure 4b). With respect to motor end-
plates, full fragmentation of the AChRs was significantly lower in
BRASTO mice compared to their age-matched controls (p < .05, Fig-
ure 4c). Similarly, the percentage of normal motor endplates in BRASTO
mice was approximately double that of their age-matched controls at
both25 and33 months of age (p < .05, Figure 4c). In summary, the aged
BRASTOmice showed amore youthful morphology of each of the three
mainNMJcomponentscomparedtoWTcontrols.
2.4 | DMH-specific Sirt1 knockdown results in a
more aged NMJ morphology
DMH and lateral hypothalamus (LH) neurons are responsible for pheno-
types observed in aged BRASTO mice (Satoh et al., 2013). In particular,
Sirt1 in the DMH plays a critical role in maintaining physical activity.
NMJ analyses were thus performed 3 weeks after stereotactic injec-
tions of shRNA-Sirt1 or shRNA-Ctr into the DMH of 3-month-old WT
mice. The efficiency of the lentiviral knockdown was noted to be a 65%
reduction in mRNA (data not shown) and similar to previous reports
(Satoh et al., 2013). DMH-specific Sirt1 knockdown accelerated age-
associated NMJ morphologic changes compared to age-matched con-
trols (Figures 5 and 6). A variety of tSC morphological abnormalities
(Figure 5) not observed in normal, healthy NMJs in control mice
(13.6  0.74%, p < .05; Figure 6a) was also seen in the NMJs from
DMH-specific Sirt1 knockdown mice. tSCs demonstrated atypically
large and intensively stained cell bodies (Figure 5d), often observed out-
side the NMJ area (Figure 5e), and many were also lightly stained with
S100 Ab with some processes (Figure 5f). In addition, the number of
tSCs associated with each endplate was less in shRNA-Sirt1 mice (Fig-
ure 6). On average, NMJs had 2.98  0.11 associated tSCs in shRNA-
Ctr mice, and the majority of NMJs had three or four tSCs (Figure 6b,c).
In contrast, the average number of tSCs per NMJ was 2.03  0.13 in
DMH-specific Sirt1 knockdown mice, and many NMJs had only one to
two tSCs per NMJ, reflecting a decrease in the distribution of tSC
numbers per NMJ. Nerve terminal abnormalities were increased
(9.4  3.1% with partially and fully denervated NMJs, p < .05, Fig-
ures 5g–h and 6a) similar to age-related NMJ innervation anomalies.
DMH-specific Sirt1 knockdown, however, did not induce postsynap-
tic AChR fragmentation (Figures 5 and 6a), in contrast to age-related
AChR fragmentation. In summary, DMH-specific Sirt1 knockdown
resulted in more abnormalities of NMJ components. While some of
the tSC morphologic changes differed from those observed in aged
mice, the increased frequency of NMJ abnormalities is similar to the
aged NMJ.
F IGURE 2 Advancing age results in more frequent NMJ morphological alterations in sternomastoid muscle of WT mice. (a) Top images
show decrease in tSC (green) number and staining intensity with age. Graph represents the percentage of NMJs with tSCs. (b) Top images
(from left to right side) represent examples of fully, partially, and not innervated (green) NMJs, respectively. Graphs show the proportions of
NMJs with the three degrees of innervation (left graph) and the percentage of fully denervated NMJs (right graph). (c) Top images (from left to
right side) represent examples of normal, partially, and fully fragmented AChRs (red), respectively. Graphs show the proportion of NMJs with
the three classifications of endplate fragmentation (left graph) and the percentage of fully fragmented AChRs (right graph). S100 Ab (for tSCs,
a); NF200 Ab (for neurofilaments, b); BTX = a-bungarotoxin (for AChRs, a–c); DAPI = nuclear staining (blue, a–c); Scale bar = 20 lm.
Data  SD; different letter indicates significant difference; p < .05
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2.5 | Muscle force did not correlate with age or
Sirt1 expression
Tetanic muscle force assessments are summarized for all genotypes
in Table 2. Tetanic muscle force was assessed at 3, 14, 17, and 25
months of age in the EDL muscles of WT mice. While there was a
significant decrease in force between 3 and 14 months of age
(27.53 N/cm2 vs. 17.42 N/cm2, p < .05), muscle force measurements
did not remain low for 17- and 25-month-old mice (25.34 and
21.18 N/cm2, respectively; p > .05). No differences in muscle force
were noted between BRASTO mice and their age-matched controls
at 16 months of age. In the EDL muscles of DMH-specific Sirt1
knockdown mice and their age-matched controls, tetanic muscle
force varied widely among animals, ranging from 15.4 to 40.2 N/cm2
(average 26.57  6.21 N/cm2) in DMH-specific Sirt1 knockdown
mice compared to forces ranging from 17.3 to 32.9 N/cm2 (average
23.39  6.04 N/cm2) in controls (p > .05).
2.6 | Sympathetic innervation is present at the
NMJ and increased in BRASTO mice
We demonstrated that BRASTO mice have a more youthful NMJ
morphology, whereas DMH-specific Sirt1 knockdown mice display a
more aged NMJ morphology. We hypothesized that the systemic
Ctr 7 m BRASTO 7 m
 S100 BTX DAPI
Ctr 7 m BRASTO 7 m
Ctr 25 m
Ctr 25 m BRASTO 25 m
BRASTO 25 m
 S100 BTX DAPI
  NF200 BTX DAPI





F IGURE 3 NMJ morphology in
BRASTO mice and age-matched controls.
NMJ morphology in young (7-month-old)
BRASTO mice (b, d) did not differ from
characteristic, healthy NMJ morphology
seen in age-matched controls (a, c). Aged
(25-month-old) BRASTO (f, h) mice have a
more youthful NMJ morphology than age-
matched control (Ctr) mice (e, g). NMJs in
BRASTO mice have distinct tSCs, clear
innervation (arrow), and pretzel-shaped
motor endplates (arrowhead in f, h) in
contrast to the fewer tSCs, incomplete or
absent innervation, and fragmented AChRs
(arrowheads in e, g) of NMJs in Ctr mice.
Representative images of NMJs from
sternomastoid muscle stained with S100
Ab (for tSCs, green), NF200 Ab (for
neurofilaments, green), BTX (for AChRs,
red), and DAPI (nuclear staining, blue).
Scale bar = 20 lm
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effect of hypothalamic Sirt1 is mediated by the sympathetic nervous
system. To assess the presence of sympathetic innervation near the
NMJ, we stained SM muscles for the sympathetic markers tyrosine
hydroxylase (TH), b2-adrenoreceptor (b2-AR), and neuropeptide Y
(NPY) in aged (20-month-old) BRASTO mice and their age-matched
controls (Figure 7). All three markers demonstrated near colocaliza-
tion with BTX staining in BRASTO mice, indicating the presence of
sympathetic innervation at the NMJ. Minimal low-intensity sympa-
thetic staining was observed in aged control mice (Figure 7a,d). In
contrast, more distinct sympathetic staining was noted at NMJs of
BRASTO mice compared to control mice (Figure 7b,c,e). In addition,
TH- (Figure 7c) and NPY- (data not shown) stained axons innervated,
or were adjacent to, the NMJs (Figure 7c). Quantitative analyses
showed more than double the percentage of TH-positive and triple
the percentage of b2-AR-positive NMJs in BRASTO mice compared
to control mice (Figure 7f). A total of three b2-AR antibodies were
tested (two monoclonal and one polyclonal), and all showed similar
results. This increased percentage of b2-AR-positive NMJs appears
to be qualitatively consistent with higher mRNA expression levels of
b2-AR and higher cAMP levels in aged BRASTO skeletal muscle,
compared to those in age-matched control skeletal muscle (Satoh
et al., 2013). NPY staining also showed similar colocalization to the
NMJs (data not shown). Therefore, increased sympathetic NMJ
innervation was observed with increased Sirt1 function in the
hypothalamus.
2.7 | Sirt1 plays a protective role against age-
associated NMJ morphological abnormalities in the
SM muscle
Lastly, we compared NMJ abnormalities in WT, BRASTO, and DMH-
specific Sirt1 knockdown mice throughout all aged we examined
(Figure 8). Clearly, central overexpression of Sirt1 in aged BRASTO
mice results in a more youthful (approximately 10 months younger)
NMJ morphology, compared to age-matched controls. Contrarily,
Sirt1 knockdown in the DMH of young mice results in a more aged
(approximately 9–10 months older) NMJ morphology. Thus, these
findings indicate that hypothalamic Sirt1 plays a critical role in pro-
tecting NMJ structures during the process of aging.
3 | DISCUSSION
The aging process is associated with progressive loss of muscle mass,
termed sarcopenia, which affects 13%–24% of humans under the age
of 70 and 43%–60% of people over the age of 80 (Baumgartner et al.,
1998). Neuromuscular dysfunction is a likely etiology of sarcopenia
(Pannerec et al., 2016). Age-associated changes occur not only in
muscle and nerve, but also at the interface between the two, the
NMJ. Age-related morphologic NMJ changes have been previously
described (Balice-Gordon, 1997; Boaro et al., 1998; Chai, Vukovic,
Age (months)
25 33
Age (months) Age (months)
25 25 3333











F IGURE 4 Quantification analyses of
NMJs from aged (25- and 33-month-old)
BRASTO mice demonstrate healthier NMJ
morphologies compared to age-matched
control (Ctr) mice. (a) BRASTO mice display
more NMJs with tSC bodies compared to
Ctr at both ages. (b) NMJs from BRASTO
mice display less partially innervated with a
similar level of denervation (not innervated,
left graph) and have greater percentages of
full innervation (right graph) than Ctr. (c)
Less AChR fragmentation (left graph) and
more normal motor endplates, defined as 5
or fewer fragments, are seen in BRASTO
mice compared to age-matched Ctr.
Data  SD; *p < .05
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Dunlop, Grounds & Shavlakadze, 2011; Deschenes et al., 2010; Jang
& Van Remmen, 2010; Kawabuchi et al., 2001; Luff, 1998; McMullen
& Andrade, 2009; Smith & Chapman, 1987; Steinbach, 1981; Wernig &
Herrera, 1986), and NMJ disruption has been identified as a driver of
sarcopenia in a rodent model (Ibebunjo et al., 2013). The majority
of those studies, however, described changes in nerve terminals or
AChRs. In this study, we conducted comprehensive quantification of
the age-associated changes of all three of the main NMJ components:
tSCs, nerve terminals, and motor endplates. In addition, we demon-
strated that hypothalamic Sirt1 signaling through sympathetic innerva-
tion is critical to counteract age-associated NMJ decline.
Given their roles in synaptic function and maintenance, tSC alter-
ations could contribute to declines in muscle function with advanc-
ing age. With progressive age, we noted decreased tSC numbers at
shRNA-Ctr shRNA-Sirt1
 S100 BTX DAPI








F IGURE 5 DMH-specific knockdown of Sirt1 (shRNA-Sirt1, b, d–f, h) in 3-month-old WT mice results in a more aged NMJ morphology
compared to age-matched, control-injected mice (shRNA-Ctr, a, c, g). Representative low magnification images of whole mount sternomastoid
muscle show tSC abnormalities (less staining intensity and fewer numbers) in shRNA-Sirt1 mice (b, e, f). Note also tSC anomalies (arrows): large
and intensely stained tSC bodies (d), tSCs migrated outside of NMJ area (e), or lightly stained with few processes colocalized with AChRs (f) in
shRNA-Sirt1 mice. Less severe changes are observed for nerve terminals (h, arrows), and almost no changes are seen in motor endplates (b, d–
f). S100 Ab (for tSCs, green), NF200 Ab (for neurofilaments, green), BTX (for AChRs, red), and DAPI (nuclear staining, blue). Scale bar = 20 lm
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the WT NMJ, with abnormalities in tSC contour, staining, and cyto-
plasmic processes. Our tSC data corroborate with those of others
(Boaro et al., 1998; Chai et al., 2011; Kawabuchi et al., 2001;
Ludatscher, Silbermann, Gershon & Reznick, 1985). By 27 months of
age, tSC degeneration was noted in 35% of NMJs in mouse gastroc-
nemius in contrast to the absence of tSC degenerative changes in 6-
month-old mice (Ludatscher et al., 1985). Additionally, tSCs have
been noted to be thin, disorganized, and to only partially cover the
endplates in advanced aged mice (Chai et al., 2011; Kawabuchi et al.,
2001), similar to the tSC changes we noted in the DMH-specific
Sirt1 knockdown mice in this study. The functional sequelae of loss
of tSC structure and number are unknown. Age-related tSC loss,
migration, and disorganization have been hypothesized to be related
to myofiber denervation (Chai et al., 2011; Connor, Suzuki, Lee,
Sewall & Heisey, 2002). Connor et al. (2002) noted extension of tSC
cytoplasmic processes in 24-month-old rats in a manner similar to
that seen after denervation (Connor et al., 2002), and Kawabuchi
et al. (2001) noted similar findings in 24-month-old mice (Kawabuchi
et al., 2001). Whether muscle denervation is a cause or effect of tSC
changes, however, has not been conclusively demonstrated.
Nerve terminal morphology was also impacted by age in WT ani-
mals. Nerve terminals showed less branching with advancing age,
and NMJ innervation declined with age. Similar morphological
changes were noted in the DMH-specific Sirt1 knockdown mice.
These findings suggest minimal motor nerve sprouting associated
with remodeling, possibly resulting in permanent denervation for
some muscle fibers. High numbers of denervated or partially inner-
vated synapses with extremes of age have been previously described
by others (Banker, Kelly & Robbins, 1983; Chai et al., 2011; Valdez,
Tapia, Lichtman, Fox & Sanes, 2012).
Fragmentation of AChRs was noted in our study, and irregular
and granular endplate fragmentation has been previously noted in
aged mice (Balice-Gordon, 1997; Chai et al., 2011; Pannerec et al.,
2016; Valdez et al., 2012; Willadt, Nash & Slater, 2016). Pannerec
et al. (2016) noted an increase in AChR fragmentation from 20% of
NMJs affected in adult EDL muscle to 70% in sarcopenic muscle
(Pannerec et al., 2016). Large amounts of motor endplate loss result
in functional decline, but the functional impact of AChR fragmenta-
tion is less clear.
Alterations in nerve terminal and AChR morphology may be con-
cerning for functional decline given their roles at the NMJ. The mor-
phological changes noted in aged WT mice in our study, however,
shRNA-Ctr
shRNA-Sirt1





F IGURE 6 DMH-specific knockdown of Sirt1 (shRNA-Sirt1)
results in more aged NMJ phenotypes compared to control (shRNA-
Ctr) mice. (a) shRNA-Sirt1 mice show significantly greater
proportions of abnormalities (one or more) in tSCs and nerve
terminals, but not AChRs, compared to controls. (b) shRNA Sirt1
mice have fewer tSC bodies per NMJ compared to control mice. (c)
Similarly, the distribution of tSC numbers per NMJ is decreased
compared to controls. Data  SD; each green dot represents
average value calculated per muscle; ***p < .001, **p < .01,
*p < .05, ns=not significant




genotype EDL mass (g)
Tetanic muscle
force (N/cm2)
3 WT 0.0088  0.0014 27.53  6.91
14 WT 0.0109  0.0020 * 17.42  2.39 *
17 WT 0.0070  0.0008 25.34  3.70
25 WT 0.0100  0.0027 21.18  6.10
16 Control 0.0131  0.0008 12.51  6.35
16 BRASTO 0.0151  0.0013 9.11  2.56
3 shRNA-Ctr 0.0096  0.0014 23.39  6.04
3 shRNA-Sirt1 0.0089  0.0014 26.57  6.21
Data represent mean  SD (N = 3–8 mice/group).
*p < .05.
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did not correlate with muscle force deficits. Similarly, we did not
observe differences in muscle force between aged BRASTO and con-
trol mice and also between DMH-specific Sirt1 knockdown mice and
controls. These findings may be the result of insufficient test sensi-
tivity, insufficient time to assessment, or actual physiological com-
pensation in the muscle. A compensatory mechanism fits with initial
decline in muscle force that later improves to baseline levels. Simi-
larly, others have reported no major age-dependent physiological dif-
ferences, despite age-related morphological changes. The increased
endplate fragmentation noted by Willadt et al. (2016) did not
correlate with function; compound muscle action potential (CMAP)
amplitude was stable with age (Willadt et al., 2016). Similarly, the
absence of nerve terminals in 40% of NMJs in 34-month-old mice
did not result in major physiological changes compared to young (8-
to 12-month-old) mice (Banker et al., 1983). Functional stability
might result from compensatory mechanisms, such as motor unit
enlargement or increased synaptic vesicle release (Robbins, 1992), or
from incomplete NMJ affliction with age-related changes, as greater
than 80% denervation is required to impart a functional deficit in
muscle force (Gordon, Yang, Ayer, Stein & Tyreman, 1993). The
aging synapse, therefore, is highly compensated rather than in a pro-
gressive state of deterioration from youth.
Importantly, we demonstrated that changes in central Sirt1
expression counteract age-associated NMJ decline in skeletal muscle.
Brain-specific overexpression of Sirt1 results in a more youthful
NMJ phenotype compared to age-matched controls with respect to
all three of the main NMJ components: tSCs, nerve terminals, and
AChRs. Conversely, DMH-specific knockdown of Sirt1 resulted in
more aged tSC and NMJ morphologies (Figure 8). Of the NMJ com-
ponents, tSCs showed the biggest effect from Sirt1 knockdown
within the DMH, suggesting that tSCs may be early harbingers of
systemic or environmental change. This hypothesis requires further
investigation. Interestingly, overexpression of Sirt1 in skeletal muscle
does not delay metabolic age-related changes (White et al., 2013).
Together, these results implicate central Sirt1 expression within the
hypothalamus, rather than local or peripheral Sirt1 expression, as a
modifier of tSC and NMJ morphology.
We hypothesized that the sympathetic nervous system mediates
the effects of central Sirt1 expression on NMJ morphology. Impaired
sympathetic neural function is associated with several age-related
systemic changes (Santulli & Iaccarino, 2013), and systemic physio-
logical improvements seen in BRASTO mice result from sympathetic
stimulation (Satoh et al., 2013). In addition, the sympathetic nervous
system is present within skeletal muscle of young adult mice (Khan
β2-AR   TH   










F IGURE 7 Aged (20-month-old)
BRASTO mice with more youthful NMJs
show increased sympathetic NMJ
innervation (b, c, e, f) compared to NMJs
in age-matched Ctr (a, d, f) mice.
Sternomastoid muscles are stained with
antityrosine hydroxylase (TH, green,
arrows, a–c) and anti-b2-adrenoreceptor
(b2-AR, arrows, d, e). Postsynaptic
endplates (AChRs) and nuclei are labeled
with BTX (red, arrowheads) and DAPI
(blue), respectively. The percentages of
TH- or b2-AR-positive NMJs are shown in
panel (f) and are greater in BRASTO mice
compared to controls. Scale bar = 20 lm.
Data  SD; each green dot represents
average value calculated per animal;
**p < .01
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et al., 2016; Rudolf et al., 2013) and may modify muscle contraction,
perfusion, and metabolism (Rudolf et al., 2013). Sympathetic innerva-
tion, as indicated by TH staining, was expressed in 96% of NMJs in
the mouse EDL and 91% of those in the soleus (Khan et al., 2016).
This same study found that chemical sympathectomy resulted in
decreased NMJ size, complexity, and electrophysiologic values that
were rescued by sympathicomimetic agents. Another sympathetic
receptor that mediates responses to catecholamines, the b2-AR, is
found extensively throughout the body. While all three b-adrenergic
receptor types are present in skeletal muscle, there is a 10-fold
increased proportion of the b2 isoform in skeletal muscle (Santulli &
Iaccarino, 2013). An age-related decline in responsiveness to b2-ARs
has been proposed (Ford, Dachman, Blaschke & Hoffman, 1995), and
b2 receptor agonists have reversed age-related muscle weakness
and wasting in rats (Ryall, Plant, Gregorevic, Sillence & Lynch, 2004).
Because of the evidence supporting sympathetic innervation con-
tributing to more youthful systemic physiology and NMJ morphology
and function, we evaluated the presence of sympathetic innervation
in our models via TH, b2-AR, and NPY staining. We showed colocal-
ization of all of these markers with AChRs, confirming sympathetic
innervation at the NMJ. Interestingly, quantification of sympathetic
NMJ innervation showed a twofold increase in the NMJs (Rudolf
et al., 2013) staining for TH and a threefold increase in NMJs stain-
ing for b2-AR in BRASTO mice compared to age-matched controls.
These data suggest that the mechanism linking the more youthful
NMJ morphology associated with central Sirt1 overexpression is
sympathetically mediated. Manipulation of sympathetic innervation
and activity is required in future studies to elucidate this mechanism.
Our study demonstrates degenerative changes in the three main
NMJ components: tSCs, nerve terminals, and AChRs with advancing
age. We further illustrate brain-specific Sirt1 overexpression resulting
in more youthful morphologies of all NMJ components, as well as
more aged NMJ morphologies with DMH-specific Sirt1 knockdown.
The NMJ effects seen with manipulation of hypothalamic Sirt1
expression confirm the importance of Sirt1 in delaying age-related
changes in skeletal muscle. The mechanisms linking central Sirt1
expression with muscle structure remain to be elucidated, but the
data from this study suggest an association with sympathetic
innervation.
4 | CONCLUSIONS
Age-associated morphologic changes occur in all NMJ components,
including tSCs, nerve terminals, and AChRs, with ~80% of NMJs
exhibiting synaptic abnormalities by 17 months of age. Brain-specific
Sirt1 overexpression results in more youthful-appearing NMJs, and
DMH-specific Sirt1 knockdown effects a more aged NMJ morphol-
ogy. Differences in NMJ morphology due to Sirt1 central expression
are associated with changes in sympathetic innervation at the NMJ.
We conclude that central Sirt1 expression protects against age-
related decline in skeletal muscle, mediated via the NMJ and sympa-
thetic nervous system.
5 | EXPERIMENTAL PROCEDURES
5.1 | Mice
The analyses were performed in wild-type (WT, C57BL/6J) and
S100-GFP transgenic mice at 3, 9, 14, 17, 20, 25, 29, and 33 months
of age. S100-GFP mice (generous gift from Dr. Susan Mackinnon,
Washington University School of Medicine, St. Louis, MO) utilize the
S100B promoter to drive GFP expression in all glial cells (Feng et al.,
2000). We also used two types of Sirt1 mice: transgenic mice (7-,
16-, 20-, 25- and 33-month-old) where brain-specific Sirt1 was over-
expressed (BRASTO mice (Satoh et al., 2010, 2013) and shRNA-
Sirt1-injected mice (3-month-old) where Sirt1 was knocked down in
the DMH using lentivirus and the stereotactic injection procedure
described previously (Satoh et al., 2013)). The BRASTO mice with an
HA-tagged Sirt1 transgene driven by the mouse prion promoter were
backcrossed to C57BL/6J for 8 to 10 generations (Satoh et al.,
2010). Mice in the aging cohorts were carefully inspected every day
for all experiments, and both sexes were used for experiments. All
aged animals studied had a normal appearance, with no signs of
motor paralysis, muscle weakness, or any other type of visible
disorder.
All experimental animals were housed in a central animal facility
and were maintained pre- and postoperatively in strict accordance
with the National Institutes of Health guidelines and according to
protocols approved by the Division of Comparative Medicine at




F IGURE 8 Sirt1 plays a protective role against age-associated
NMJ morphological abnormalities in the sternomastoid muscle.
Percentages of NMJ abnormalities (≥1 in any of the 3 NMJ
components) are shown for WT, BRASTO, and DMH-specific Sirt1
knockdown (shRNA-Sirt1) mice at differing ages. Young adult mice
(age 3 months) with DMH-specific Sirt1 knockdown (red bar) display
a more aged NMJ morphology, with a significantly greater
percentage of NMJ abnormalities than age-matched controls
(shRNA-Ctr). BRASTO mice (ages 25 and 33 months, green bars)
have a more youthful NMJ morphology, with significantly fewer
NMJ abnormalities, than age-matched controls. Data  SD; *p < .05;
different letter indicates significant difference (for 3-, 25- and 33-
month-old mice)
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5.2 | Muscle immunofluorescence staining and NMJ
imaging
After anesthesia, animals were transcardially perfused with 0.1 M
phosphate-buffered saline (PBS, pH = 7.4) with 4% paraformalde-
hyde solution (Electron Microscopy Science, Hatfield, PA, USA) in
PBS. Mouse SM muscle, which contains a relatively greater number
of NMJs compared to other muscles, thereby providing an excellent
model for NMJ evaluation, was selected for our studies. SM muscles
from both sides of the neck were dissected and postfixed overnight
at 4°C. For immunofluorescence labeling of NMJ components, mus-
cles were processed as whole mounts (Love & Thompson, 1998) or
as ~30-lm-thick longitudinal frozen sections, prepared after cryopro-
tection in 30% sucrose overnight at 4°C and embedding in OCT
(Tissue-Tek, Miles, Elkhart, IN, USA). All OCT specimens were stored
at 80°C until use. Whole muscles or frozen sections were blocked
and permeabilized first in the blocking buffer (2% normal goat
serum, 2% Triton X-100, 5 % bovine serum albumin in PBS) for 1 hr
at room temperature followed by staining with the primary antibody
overnight at 4°C. The following primary antibodies (Abs) were used:
rabbit anti-S100 (1:1,000; Dako North America, Via Real, Carpinte-
ria, CA, USA) to visualize all Schwann cells (SCs), mouse antisynaptic
vesicle protein 2 (SV2; 1:20; Developmental Studies Hybridoma
Bank, Iowa City, IA, USA), rabbit antineurofilament 200 (NF200,
1:500; Millipore Sigma, St. Louis, MO, USA), mouse and rabbit anti-
b2-adrenergic receptors (b2-AR; 1:200; Santa Cruz Biotechnology,
Inc., Dallas, TX, USA), rabbit monoclonal antineuropeptide Y (NPY;
1:50; Cell Signaling Technology, Inc., Boston, MA, USA), and rabbit
antityrosine hydroxylase (TH; 1:50; EMD Millipore Corporation,
Temecula, CA, USA). After rinsing in washing buffer (PBS with 2%
Triton X-100), sections (or muscles) were incubated with goat anti-
rabbit IgG-Alexa Fluor 488 or goat anti-rabbit IgG-Alexa Fluor 594,
and goat anti-mouse IgG-Alexa Fluor 488 (1:1,000; Invitrogen-Mole-
cular Probes, Carlsbad, CA, USA). After further rinsing in washing
buffer, tissues were incubated with Alexa Fluor 555-a-BTX (1:1,000;
Molecular Probes, Eugene, OR, USA), which binds specifically to
AChRs in the postsynaptic membrane, thereby marking synaptic
sites. Control sections (either no primary or no secondary antibody)
were included in every type of staining to test for nonspecific stain-
ing and autofluorescence. Slides were prepared using Vectashield
mounting medium with DAPI (Vector Laboratories, Inc. Burlingame,
CA, USA) to label nuclei.
5.3 | NMJ analysis and quantification
NMJ analyses were performed on whole mounts and frozen sections of
the SMmuscles (Love & Thompson, 1998; Valdez et al., 2010). To facili-
tate whole mount imaging, the entire SM muscle was flat mounted in
Vectashield mounting medium with a coverslip. Morphologic changes
between young adult and aging mice were analyzed in three major NMJ
components: tSCs (S100 Ab labeling), the presynaptic nerve terminals
(NF200/SV2 Abs labeling), and postsynaptic AChRs on the motor end-
plate (a-BTX labeling). The whole mount muscle and muscle sections
were imaged using an Axio Imager M2 fluorescent microscope (Zeiss,
Thornwood, NY, USA). High-resolution confocal images were obtained
using a FluoView FV1000 confocal microscope (Olympus, Center Val-
ley, PA, USA). Sequential capture was used to separate the green and
red channels in order to prevent crosstalk between dyes, and Z-serial
images were collected with a 209, 409, and 639 objectives. Maximum
intensity projections were obtained by epifluorescence scope or Olym-
pus FluoView software and saved as TIFF and oib files. Whenever pos-
sible, image acquisition parameters remained constant. Images were
viewed and analyzed using NIH ImageJ (http://rsb.info.nih.gov/iJ/), and
figures were prepared using Excel, Adobe Photoshop CC 2015, and
Adobe Illustrator CC 2015 system (Adobe Systems, San Jose, CA, USA).
For quantitative analysis, muscle sections from three to nine ani-
mals from each age-group were processed. At least 15 sections and
at least six or more macroscopic fields of view/section were analyzed
per muscle totaling >100 NMJs per muscle. The sections selected for
staining were from different parts of the muscle, but more sections
were analyzed from middle portion of the muscle where the NMJ dis-
tributions were nearly identical at any sectioning level. All quantita-
tive analyses were confirmed via blinded evaluators.
The three cellular components lying in close apposition at the
NMJs—tSCs with their processes, motor nerve terminals, and AChRs
—were evaluated. Only NMJs with motor endplates lying en face in
the major plane of section were selected for quantification. Muscles
where antibody staining was too faint to quantify due to poor anti-
body penetration were excluded from further analysis.
The percent of NMJs with tSCs (cell bodies) and the number of
tSCs present per NMJ were determined in images labeled with S100
Ab, a-BTX, and DAPI (Love & Thompson, 1998). Because multiple
DAPI-labeled nuclei are located at the NMJ, tSC identification was
performed with care. The confocal z-stacks were manually scanned
above and below the endplate to identify the number of DAPI-posi-
tive nuclei corresponding to S100 staining.
NMJ innervation (mostly or completely apposed endplates,
stained with NF200/SV2 Abs, a-BTX, and DAPI) was determined by
classifying each NMJ in a given field of view as fully innervated
(nerve terminal completely overlies a-BTX), partially innervated
(nerve terminal only partially covers a-BTX), or vacant (no nerve ter-
minal overlying the endplate) (Valdez et al., 2012). To ensure that
lack of nerve terminal staining is not simply due to poor antibody
penetration, surrounding NMJs and endplates were carefully
observed. Diffused and/or reduced intensity of endplate staining,
caused by the lack of neuronal signal and subsequent AChR disper-
sal, is an indicator of denervation.
The morphological changes in AChRs stained with a-BTX and
DAPI were determined by classifying endplates as normal (AChRs
form a continuous structure also described as pretzel-like, showing
five or fewer fragments), partially fragmented (AChRs with more
than five fragments or one irregular structure), or fully fragmented
(AChRs with patchy or granular distribution). Most NMJs in young
adult mice contain fewer than five AChR islands (Li et al., 2011).
The presence of sympathetic innervation at the NMJs was ana-
lyzed in the SM muscle sections from 20-month-old BRASTO (n = 4)
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and control (n = 3) mice stained with antibodies against b2-AR, NPY,
and TH in combination with a-BTX and DAPI.
5.4 | Preparation of lentiviruses expressing shRNA-
Sirt1 and shRNA-Ctr
For a loss-of-function approach, we used short hairpin RNA (shRNA)
to knock down the endogenous expression of Sirt1 from the DMH.
shRNA-Sirt1 and control (shRNA-Ctr) lentivirus were prepared in the
Hope Center Viral Vectors Core at Washington University School of
Medicine as described previously (Satoh et al., 2013). Lentivirus was
produced by cotransfecting HEK293T cells with vectors containing
the firefly luciferase or Sirt1 shRNA via the calcium phosphate precip-
itation procedure (Li et al., 2010). Virus with titer of 3.6 to
4.3 9 108 TU/ml was used for stereotactic injection (see below).
Knockdown efficiency was tested using primary hypothalamic neu-
ronal cultures. Total RNA was extracted using the Pure Link RNA
Mini kit (Ambion by Life Technologies, Carlsbad, CA, USA). Quantita-
tive real-time RT–PCR was conducted using primer–probe combina-
tion obtained from Applied Biosystems TaqMan Gene Expression
Assays (Life Technologies), and relative expression levels were calcu-
lated for Sirt1 by normalizing to Gapdh levels and then to one of the
WT control individuals as previously described (Satoh et al., 2013).
Transcript level fold change was determined by the delta CT
method. All measurements were made in triplicate. Student’s t test
was performed to compare fold change. Two separate lentivirus
samples were made for two different injection experiments.
5.5 | Stereotactic injection of lentivirus expressing
Sirt1 or firefly luciferase shRNA into the DMH
WT mice (3-month-old; n = 4 mice/group/experiment; n = 2 experi-
ments) were used for stereotactic injection of experimental (shRNA-
Sirt1) or control (shRNA-Ctr) lentivirus. The injection was performed
under aseptic technique at the Animal Surgery Core at Washington
University School of Medicine according to the method previously
described in detail (Satoh et al., 2013). Immediately after the injection,
animals were allowed to recover in a temperature regulated incubator
(32°C) until fully awake and then were transferred to an isolated ani-
mal room for 72 hr and maintained without disturbance. All injected
mice had 3 weeks to fully recover before being used for tissue collec-
tion. All procedures were in compliance with NIH Guidelines for
Research Involving Recombinant DNA Molecules, and all animal usage
methods were approved by the Division of Comparative Medicine and
Institutional Animal Committee at Washington University.
5.6 | Tetanic muscle force testing
Young adult WT, aged WT, DMH-specific Sirt1 knockdown mice,
and BRASTO with their control mice were used for measuring the
evoked compound action potential (cMAP) in the extensor digitorum
longus (EDL) muscle upon electrical stimulation of the sciatic nerve
as described previously in detail (Santosa et al., 2013). Animals were
anesthetized and immobilized in an automated functional station
(FASt System, Red Rock laboratories, St. Louis, MO, USA). Twitch
contractions were used to estimate the optimal stimulus amplitude
and optimal muscle length for isometric force production in the EDL
muscle, with the distal muscle tendon fixed to a 5 Newton (N) load
cell. The EDL, instead of SM, muscle was utilized as it has a long
tendon, which is required to facilitate the fixation to the load cell.
Tetanic contractions were recorded at increasing frequencies of
stimulation (5–200 Hz), allowing 2-min intervals between stimuli to
prevent muscle fatigue. Maximum isometric tetanic force was auto-
matically calculated from the resulting sets of recorded force traces.
Following assessment, animals were euthanized, the dissected EDL
muscle was weighed, and the tetanic specific muscle force (N/cm2)
was calculated by dividing the absolute muscle force by the physio-
logical muscle cross-sectional area. A total of 3–8 animals per group
were assessed.
5.7 | Statistical analyses
All data are presented as the mean  SD. Significance is shown as
*p < .05. Quantifications were performed from at least three experi-
mental groups in a blinded fashion unless otherwise noted. Statistical
analyses were performed by two-tailed, unpaired Student’s t tests,
or one-way ANOVA followed by a Bonferroni post hoc test. All anal-
yses were performed using Microsoft Excel, GRAPHPAD PRISM 6.00 (San
Diego, CA, USA; http://www.graphpad.com), and SPSS (SPSS Inc., Chi-
cago, IL, USA).
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